High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era. [electronic resource]
Producer: 20160725Description: 1-6 p. digitalISSN:- 1873-5835
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Area Under Curve
- Bone Marrow -- pathology
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Humans
- Image Interpretation, Computer-Assisted
- Kaplan-Meier Estimate
- Lymphoma, Large B-Cell, Diffuse -- metabolism
- Male
- Middle Aged
- Multimodal Imaging
- Positron-Emission Tomography
- Prednisone -- therapeutic use
- Prognosis
- Proportional Hazards Models
- ROC Curve
- Rituximab -- therapeutic use
- Tomography, X-Ray Computed
- Tumor Burden
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.